Aromatase Inhibitors and Inactivators for Breast Cancer Therapy

ISSN： 1170-229X

Source： Drugs & Aging, Vol.19, Iss.4, 2002-04, pp. : 277-298

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Pharmacokinetics of Aromatase Inhibitors and Inactivators

By Lønning Per E.

Clinical Pharmacokinetics, Vol. 42, Iss. 7, 2003-01 ,pp. : 619-631

Adis International

Access to resources Recommend Favorite

The Aromatase Inhibitors as Adjuvant Therapy for Hormone Receptor-Positive Breast Cancer

By Ligibel Jennifer A. Winer Eric P.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 1, Iss. 2, 2003-04 ,pp. : 215-221

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Aromatase inhibitors and breast cancer prevention

By Litton Jennifer Keating Arun Banu K Brown Powel H Hortobagyi Gabriel N

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 3, 2012-02 ,pp. : 325-331

Informa Healthcare

Access to resources Recommend Favorite

Aromatase Inhibitors in the Treatment of Postmenopausal Breast Cancer

By Bajetta E.

Drugs & Aging, Vol. 15, Iss. 4, 1999-10 ,pp. : 271-283

Adis International

Access to resources Recommend Favorite

Aromatase inhibitors for breast cancer: pharmacoeconomic considerations

By Higa Gerald M

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 6, 2001-06 ,pp. : 987-995

Informa Healthcare

Access to resources Recommend Favorite